LAD1, ladinin 1, 3898

N. diseases: 87; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Congenital disorder of glycosylation, type 2C
0.050 GeneticVariation disease BEFREE Leukocyte adhesion deficiency type II (LAD II) is a rare disorder characterized by recurrent infections, persistent leukocytosis, and severe mental and growth retardation. 10571012 1999
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.040 GeneticVariation disease BEFREE Logistic regression analysis showed that LAD and LVEDD (both p < 0.001), rather than the C allele of the CYP11B2 gene (p= 0.107) were significant predictors for AF. 21846681 2011
CUI: C0004238
Disease: Atrial Fibrillation
Atrial Fibrillation
0.040 GeneticVariation disease BEFREE After adjustment for age, sex, hypertension and LAD, there was no association between the rs1800469 polymorphism and the risk of AF under the dominant, recessive and additive genetic models. 24349426 2013
Diabetes Mellitus, Insulin-Dependent
0.040 GeneticVariation disease BEFREE Two hundred and fifty patients identified as LADA, divided into two subgroups with low (< or = 32 arbitrary units) or high (> 32 units) GADA titre, 620 subjects with Type 2 diabetes [from the Non-Insulin Requiring Autoimmune Diabetes (NIRAD) study cohort of 5330 subjects] in addition to 551 consecutive cases of Type 1 diabetes and 545 normoglycaemic subjects were analysed for the rs12255372 and rs7903146 polymorphisms of the TCF7L2 gene using Taqman. 20546291 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.030 GeneticVariation disease BEFREE From Type 1, through LADA, to type 2 diabetes: a continuous spectrum? 19120276 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.030 GeneticVariation disease BEFREE Two hundred and fifty patients identified as LADA, divided into two subgroups with low (< or = 32 arbitrary units) or high (> 32 units) GADA titre, 620 subjects with Type 2 diabetes [from the Non-Insulin Requiring Autoimmune Diabetes (NIRAD) study cohort of 5330 subjects] in addition to 551 consecutive cases of Type 1 diabetes and 545 normoglycaemic subjects were analysed for the rs12255372 and rs7903146 polymorphisms of the TCF7L2 gene using Taqman. 20546291 2010
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.030 GeneticVariation group BEFREE After adjustment for age, sex, hypertension and LAD, there was no association between the rs1800469 polymorphism and the risk of AF under the dominant, recessive and additive genetic models. 24349426 2013
CUI: C0020538
Disease: Hypertensive disease
Hypertensive disease
0.030 GeneticVariation group BEFREE In multilocus haplotype analysis, the association between frequencies of the haplotypes and AF risk was showed in AGT gene (rs7539020-rs3789678), compared 'TT' haplotype with the common 'TC' haplotype, adjusted for age, gender, LVEF, LVEDD, LAD and frequency of hypertension and diabetes. 25723521 2015
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.030 GeneticVariation group BEFREE Cardiac output (CO), maximal pressure in the LV (Pmax in-LV), stroke volume (SV), left ventricular ejection fraction (LVEF), diastolic durations, heart rate, and arterial systemic pressure were evaluated with conductance catheters for the following periods: basal (before SMR), SMR with patent LAD, and SMR with occluded LAD. 29327562 2018
CUI: C0205734
Disease: Diabetes, Autoimmune
Diabetes, Autoimmune
0.030 GeneticVariation disease BEFREE We previously demonstrated the presence of two different populations among adult-onset autoimmune diabetes (latent autoimmume diabetes of adults; LADA) having high or low titre of antibodies to glutamic acid decarboxylase (GADA). 20546291 2010
CUI: C0205734
Disease: Diabetes, Autoimmune
Diabetes, Autoimmune
0.030 GeneticVariation disease BEFREE Ninety-eight patients with type 1 diabetes (median age, 35 years; range, 9-89 years and 51 patients with latent autoimmune diabetes (LADA; median age, 48 years; range, 19-79 years) were compared with 113 healthy control patients (median age, 35 years; range, 19-65 years) to study the importance of MICA-microsatellite polymorphism and HLA-DR-DQ as genetic risk factors for diabetes. 12941547 2003
ST segment elevation myocardial infarction
0.030 GeneticVariation disease BEFREE The first randomized controlled trial in patients with CTOs recently reported that patients with ST elevation myocardial infarction (STEMI) and a CTO in the non-culprit vessel showed an improvement in ejection fraction in patients undergoing CTO PCI of the LAD, but not other vessels. 28315181 2017
ST segment elevation myocardial infarction
0.030 GeneticVariation disease BEFREE Multivariable analysis showed that presentation with STEMI (odds ratio [OR]: 2.71, P = 0.001), troponin I >50 µg/L (OR: 1.02, P = 0.005), and SCAD involvement of the LAD (OR: 2.5, P = 0.002) were independent predictors of baseline LVEF <50%. 28218398 2017
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.020 GeneticVariation group BEFREE This report clearly illustrates the differences in terms of autoimmunity (prevalence and titer of GAD and IA2 antibodies) and HLA class II genotype between patients with LADA and those with juvenile type 1 diabetes. 17395515 2007
CUI: C0004364
Disease: Autoimmune Diseases
Autoimmune Diseases
0.020 GeneticVariation group BEFREE There were significant associations of risk T allel of the analyzed polymorphism with all studied autoimmune diseases (GDOR = 1.34, p = 7.02e-03; MSOR = 1.36, p = 2.17e-02; LADA - OR = 3.36, p = 8.73e-07). 31733941 2020
CUI: C0026769
Disease: Multiple Sclerosis
Multiple Sclerosis
0.020 GeneticVariation disease BEFREE This study showed an association of rs1990760 polymorphism in the IFIH1 gene in the development of GD, LADA diabetes and MS within the Polish population. 31733941 2020
CUI: C0018213
Disease: Graves Disease
Graves Disease
0.010 GeneticVariation disease BEFREE The aim of the present study was to analyse a possible association of three autoimmune disabilities - Multiple sclerosis (MS), LADA diabetes and Graves' disease (GD) with single nucleotide polymorphism (SNP; rs1990760) in the IF IH1 gene (also known as a melanoma differentiation-associated protein 5 - MDA5) within the Polish population. 31733941 2020
CUI: C0037299
Disease: Skin Ulcer
Skin Ulcer
0.010 GeneticVariation phenotype BEFREE Here we present four Indian patients with LAD-I from three unrelated families initially diagnosed as PG due to chronic recurrent skin ulcerations requiring steroids and antibiotics for healing, associated with atrophic scar formation. 25876705 2015
CUI: C0042345
Disease: Varicosity
Varicosity
0.010 GeneticVariation disease BEFREE The CPF was supplied by multiple branches from the LAD and RCA, and formed a complex common varicosity with multiple drainage channels to the pulmonary artery. 30019821 2018
CUI: C0085096
Disease: Peripheral Vascular Diseases
Peripheral Vascular Diseases
0.010 GeneticVariation group BEFREE Independent predictors of MACE were cardiogenic shock (HR 2.54; 95%CI 1.75-3.70; p<0.001), ST in LAD (HR 1.76; 95%CI 1.32-2.35; p<0.001) prior CVA/TIA (HR 1.68; 95%CI 1.08-2.62; p=0.020), peripheral vascular disease (HR 1.55; 95%CI 1.00-2.39; p=0.046), multivessel disease (HR 1.53; 95%CI 1.12-2.08; p=0.007), and final TIMI flow 2-3 (HR 0.54; 95% CI 0.34-0.85; p=0.009). 31475906 2019
CUI: C0265191
Disease: Chronic acquired lymphedema
Chronic acquired lymphedema
0.010 GeneticVariation disease BEFREE Truncular venous malformations and acquired functional or anatomical venous occlusions (or sub-occlusions) can be the cause of secondary lymphedema and even the cause of primary lymphedema when they are associated with lymphatic malformations (lymphangiodysplasia - LAD I, lymphadenodysplasia - LAD II, or a combination of both) in pediatric patients. 30234251 2017
CUI: C0398368
Disease: Lymphatic Abnormalities
Lymphatic Abnormalities
0.010 GeneticVariation group BEFREE Truncular venous malformations and acquired functional or anatomical venous occlusions (or sub-occlusions) can be the cause of secondary lymphedema and even the cause of primary lymphedema when they are associated with lymphatic malformations (lymphangiodysplasia - LAD I, lymphadenodysplasia - LAD II, or a combination of both) in pediatric patients. 30234251 2017
CUI: C0856737
Disease: Single vessel disease
Single vessel disease
0.010 GeneticVariation disease BEFREE The prevalence of single-vessel disease (odd ratio [OR] = 2.490; 95% confidential interval [95% CI] = 1.376-4.506; P = .002), total LAD occlusion (OR = 1.897; 95% CI = 1.024-3.515; P = .041), absence of previous angina (OR = 1.930; 95% CI = 1.035-3.600; P = .037), time between myocardial infraction (MI) and coronary angiography more than 12 h (OR = 1.970; 95% CI = 1.044-3.719; P = .035), GFR less than 60 mL/min (OR = 2.933; 95% CI = 1.564-5.503; P = .001), and ferritin levels (P = .0003) were all higher in the aneurysm group compared with those in the control group. 30170438 2018
CUI: C0935560
Disease: Multiple disability
Multiple disability
0.010 GeneticVariation disease BEFREE The aim of the present study was to analyse a possible association of three autoimmune disabilities - Multiple sclerosis (MS), LADA diabetes and Graves' disease (GD) with single nucleotide polymorphism (SNP; rs1990760) in the IF IH1 gene (also known as a melanoma differentiation-associated protein 5 - MDA5) within the Polish population. 31733941 2020
CUI: C0948008
Disease: Ischemic stroke
Ischemic stroke
0.010 GeneticVariation disease BEFREE Additionally, Cox proportional analysis indicated that the miR‑150GA genotype was associated with survival in patients with ischemic stroke [adjusted hazard ratio (HR), 2.063; 95% CI, 1.142-3.727; P=0.017] and with the LAD subgroup [adjusted HR, 3.021; 95% CI, 1.345-6.785; P=0.008]. 27246008 2016